Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 July 2023 14 July 2023NewsVeterinaryMedicines EMA statement on ongoing review of GLP-1 receptor agonists 11 July 2023NewsHuman Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3 - 6 July 2023 7 July 2023NewsHumanPharmacovigilanceReferrals Phasing out of extraordinary COVID-19 regulatory flexibilities 6 July 2023NewsHumanCOVID-19 Global regulators confirm good safety profile of COVID-19 vaccines 5 July 2023NewsHumanCOVID-19Medicines Use of real-world evidence in regulatory decision making – EMA publishes review of its studies 23 June 2023NewsHumanData on medicines Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 June 2023 23 June 2023NewsHumanMedicines ACT EU: creating a better environment for clinical trials through collaboration 22 June 2023NewsHumanClinical trials Report: How EU ensured safety of medicines during COVID-19 22 June 2023NewsHumanPharmacovigilance Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 13-15 June 2023 16 June 2023NewsVeterinaryMaximum residue limitMedicines 1 … 25 26 27 28 29 Page 29 of 380 30 31 32 33 … 380
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 11-13 July 2023 14 July 2023NewsVeterinaryMedicines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3 - 6 July 2023 7 July 2023NewsHumanPharmacovigilanceReferrals
Global regulators confirm good safety profile of COVID-19 vaccines 5 July 2023NewsHumanCOVID-19Medicines
Use of real-world evidence in regulatory decision making – EMA publishes review of its studies 23 June 2023NewsHumanData on medicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 June 2023 23 June 2023NewsHumanMedicines
ACT EU: creating a better environment for clinical trials through collaboration 22 June 2023NewsHumanClinical trials
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 13-15 June 2023 16 June 2023NewsVeterinaryMaximum residue limitMedicines